2 exciting ETFs named as buys by experts

Here are two ETFs that could be buys…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're wanting to buy some exchange traded funds (ETFs), then you certainly have a lot of options.

But which ones could be buys? Two that have been tipped as buys by analysts are listed below. Here's what they are saying about them:

A young woman sits with her hand to her chin staring off to the side thinking about her investments.

Image source: Getty Images

ETFS Battery Tech & Lithium ETF (ASX: ACDC)

If you're wanting to get some exposure to the decarbonisation megatrend, then the ETFS Battery Tech & Lithium ETF could be one way to do it.

This popular ETF allows investors to buy a slice of companies involved in battery technology, electric vehicles, and lithium mining. This includes BYD, Mineral Resources Limited (ASX: MIN), Pilbara Minerals Ltd (ASX: PLS), Nissan, and Renault.

Jessica Amir from Saxo Markets is positive on the ETF. Especially for investors that aren't keen on stock picking in the lithium sector. She commented:

If stock picking is not for you, and if you believe, like we do, that the electric vehicle industry and the critical minerals/ commodities will continue to see rising demand, and policy support, and also benefit from the world striving to be carbon neutral by 2050, then you could invest or trade in Global X Lithium & Battery Tech ETF (LIT) or ETFS Battery Tech & Lithium ETF (ACDC) that invests in about 30 of the biggest EV and battery technology companies in the world.

ETFS S&P Biotech ETF (ASX: CURE)

Another ETF that has been tipped as a buy is the ETFS S&P Biotech ETF. As its name implies, this ETF gives investors access to U.S. healthcare biotechnology companies.

The fund manager notes that these companies are engaged in the research, development and manufacturing of products based on genetic analysis and genetic engineering. This includes the development of immunotherapy treatments and vaccines to treat human diseases.

Among its largest holdings are ChemoCentryx, Global Blood Therapeutics, and Twist Bioscience.

Felicity Thomas from Shaw & Partners is a fan of the ETF. She recently told Livewire:

I like to buy ETFs for the long term. We have an ageing population, and what's the most important thing in the world? Your health. Biotech, healthcare, and life sciences, that's where you want to be invested over the next couple of decades.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ETFs

A young well-dressed couple at a luxury resort celebrate successful life choices.
ETFs

Why I think these Vanguard ETFs could outperform the ASX 200

The ASX 200 has delivered solid returns, but I wouldn’t limit a long-term portfolio to Australian shares.

Read more »

Four businessmen pull martial arts stances as they get into a defensive position.
ETFs

3 defensive ASX ETFs to battle through market turmoil

One strategy to protect your portfolio.

Read more »

A banker uses his hands to protect a pile of coins on his desk, indicating a possible inflation hedge.
ETFs

These 3 ASX ETFs can protect your portfolio against inflation

With inflation on the rise, investors should think about protecting their assets.

Read more »

Businessman working on street in New York. Dressing in blue suit, a young guy with beard, sitting outside office building, looking down, reading, typing on laptop computer.
ETFs

Why now could be the best time in years to buy NDQ and these ETFs

These ETFs have been sold-off recently. Let's see why that could be a buying opportunity.

Read more »

Three smiling corporate people examine a model of a new building complex.
ETFs

The best ASX ETFs to buy for building wealth in 2026 and beyond

Wanting to build wealth? These funds could help you on your journey.

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
ETFs

Look long-term with these 3 ASX ETFs

These can be set and forget funds for your portfolio.

Read more »

man sitting in hammock on beach representing asx shares to buy for retirement
ETFs

Just 3 ASX ETFs could build a lazy Australian millionaire portfolio

Diversified ETF investments have also proven to be very resilient in turbulent markets.

Read more »

ETF in blue with person's hand in the direction of green and red bars on graph.
ETFs

How these 2 ASX ETFs benefit from Chinese innovation: Expert

These two funds could be worth adding to your portfolio.

Read more »